Skip to main content
Clinical Trials/IRCT201506079014N67
IRCT201506079014N67
Completed
Phase 2

Effect of local injection of botulinum toxin versus nasal fluticasone spray on clinical sign and symptoms in patients with allergic rhinitis: a triple blind randomized clinical trial

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 sites74 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Allergic rhinitis.
Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Enrollment
74
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • (a) age of 18 to 70 years; (b) having allergic rhinitis.
  • Exclusion criteria: (a) pregnancy or breastfeeding; (b) contraindication of corticosteroids; (c) having severe anatomical abnormality in nose or acute rinosinusitis; (d) having glaucoma or prostatic hypertrophy; (e) having severe systemic diseases such as diabetes or asthma; (f) simultaneous using aminoglycoside drugs.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials